Methods and systems
The computer-implemented method optimizes the assignment of medical samples to analytical tests by assessing compliance and implementing mitigation measures, addressing sample quality issues to reduce invalid results and enhance laboratory throughput and patient care.
Patent Information
- Application Number
- JP2024074438
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-05
- Filing Date
- 2024-05-01
- Publication Date
- 2024-11-15
AI Technical Summary
Approximately two-thirds of laboratory test errors and invalid results are due to sample collection, handling, and processing issues before the sample reaches the laboratory, leading to wasted resources, delayed medical interventions, and reduced laboratory throughput.
A computer-implemented method and system optimize the assignment of medical samples to analytical tests by determining compliance status and implementing mitigation measures to ensure sample quality meets test specifications, reducing wasteful consumption of resources and increasing laboratory throughput.
The method reduces the number of invalid test results by ensuring sample quality meets analytical test specifications, thereby minimizing resource waste and enabling timely medical interventions, thus improving patient outcomes and laboratory efficiency.
Smart Images

Figure 2024160991000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a computer-implemented method and analytical test management system for optimizing the allocation of medical samples to analytical tests. [Background technology]
[0002] According to the literature, approximately two-thirds of errors and invalid results associated with laboratory testing are due to sample collection, handling, and processing before the sample arrives at the laboratory.
[0003] Beginning with the collection of the patient sample, several activities occur before the sample arrives at the laboratory that can affect the success of the subsequent laboratory test. Multiple factors can affect the quality of the sample (e.g., time, temperature exposure, light exposure, shock, humidity).
[0004] Laboratory tests that produce errors and invalid results are undesirable for several reasons. First, such laboratory tests waste the time of patients, medical professionals and laboratory staff. Furthermore, subsequent medical interventions may be delayed based on the results of these laboratory tests, which may be detrimental to patient outcomes. It is also a waste of physical resources, both in the collection of samples and in the testing of these samples. Finally, performing tests that produce invalid results reduces useful laboratory throughput (i.e., the throughput of samples that produce valid test results).
[0005] The present invention has been made in view of the above considerations. Summary of the Invention
[0006] According to a first aspect, a computer-implemented method is provided for optimizing the allocation of one or more medical samples to one or more analytical tests performed on these medical samples prior to processing of the medical samples in an analytical laboratory. The method of the first aspect includes the steps of obtaining an initial allocation of one or more medical samples to one or more analytical tests, determining a compliance status of the or each medical sample, the compliance status indicating whether (i) a sample quality metric of the or each medical sample violates an analytical test specification of the assigned analytical test of the medical sample in the initial allocation, and / or (ii) whether the or each medical sample is not processable, and performing mitigation measures prior to processing of the medical sample if the one or more compliance statuses indicate that (i) a sample quality metric of a given medical sample violates an analytical test specification and / or (ii) the given medical sample is not processable, the mitigation measures including modifying the allocation of the medical sample to the analytical test based on the or each compliance status.
[0007] Such a method can determine whether a given medical sample is compliant with the assigned analytical test, and therefore whether the assigned analytical test (i) is likely to provide a valid result if performed on the medical sample, and / or (ii) can be performed on the medical sample (whether the result is likely to be valid or invalid), respectively. By taking mitigating measures as the result of this determination requires, the method can reduce wasteful consumption of resources (e.g., both laboratory resources and sample collection resources) and increase useful laboratory throughput. Furthermore, the above method may result in better patient health outcomes, where patients avoid waiting for analytical test results that turn out to be invalid due to poor sample quality, thus enabling them to receive appropriate medical intervention earlier.
[0008] The methods described above may be performed by an analytical test management system configured to communicate with a laboratory scheduling system and possibly one or more remote agents.
[0009] It is understood that the allocation of one or more medical samples to one or more analytical tests performed on these medical samples is optimized prior to the processing of the medical samples in an analytical laboratory. The processing may be either performing a sample quality test or performing a test according to the analytical test specifications of the sample itself. For example, an aliquot of the sample may be analyzed for certain quality-related analytes to determine the quality of the sample. Alternatively, one or more analytical tests may be performed on the medical sample or an aliquot thereof. By performing the present computer-implemented method of optimizing the allocation of one or more medical samples to one or more analytical tests performed on these medical samples prior to the processing of the medical samples in an analytical laboratory, waste of laboratory resources and / or reagents may be avoided and useful laboratory throughput may be increased. The present method may be performed by an analytical test management system communicatively connected to a laboratory scheduling system (20). The analytical test management system obtains an initial allocation from the laboratory scheduling system (20) prior to processing the medical samples according to the initial allocation.
[0010] A medical sample that is described as "compliant" with an analytical test may be understood to (i) have a sample quality metric that complies with (i.e., does not violate) the analytical test specifications, and (ii) be processable (i.e., is not unprocessable).
[0011] The analytical tests may be performed on an in vitro diagnostic device or may be suitable for performing on an in vitro diagnostic device. These analytical tests may, for example, determine one or more clinically relevant values (e.g., blood glucose levels) and / or indications of one or more clinically relevant markers (e.g., the presence of a virus or an enzyme) from a sample. The in vitro diagnostic device may be a laboratory device or a point-of-care device.
[0012] The compliance status determination may include only determining whether the sample quality metric of the or each medical sample violates the analytical test specification of the assigned analytical test of the medical sample in the initial allocation. The compliance status determination may include only determining whether the or each medical sample is unprocessable. In some examples, the compliance status determination may include both determining whether the sample quality metric of the or each medical sample violates the analytical test specification of the assigned analytical test of the medical sample in the initial allocation and determining whether the or each medical sample is unprocessable. In yet another example, the compliance status determination may include first determining whether the or each medical sample is unprocessable, and then determining whether the sample quality metric of the or each medical sample violates the analytical test specification of the assigned analytical test of the medical sample in the initial allocation only for the medical samples determined to be processable.
[0013] Mitigation actions may include modifying (i.e., automatically by a computer) the initial assignment of medical samples to analytical tests based on the or each compliance status for the assigned analytical tests. Mitigation actions including modifying the assignment of medical samples to analytical tests may reduce the number of medical samples that are discarded because they are found to not comply with the analytical test specifications for the test that they were originally assigned to.
[0014] Mitigation actions may include flagging and / or invalidating test orders associated with the medical sample and respective analytical tests based on the or each compliance status, thereby bringing invalid test orders to the attention of laboratory operators and preventing them from running the test orders or relying on the results.
[0015] A lab operator may resolve a flagged test order, for example, by running the test using a point-of-care device, contacting the test orderer, or manually routing the test order to the lab schedule.
[0016] In the case of multiple compliance statuses, each indicating that a sample quality metric violates a corresponding analytical test specification and / or that the medical sample is unprocessable, different mitigating actions can be taken in response to different negative compliance statuses. In some examples, in the case of multiple compliance statuses, each indicating that a sample quality metric violates a corresponding analytical test specification and / or that the medical sample is unprocessable, the same mitigating action can be taken in response to a negative compliance status.
[0017] The mitigation action may include notifying an operator of the violation of analytical test specifications. The notification may include: (i) one or more proposed modifications of the assignment of medical samples to analytical tests, (ii) or a notice or flag based on the respective compliance status. The mitigation action may further include the operator being able to accept or reject the proposed modifications. The ability of a laboratory operator to reject the proposed modifications and decide to run the test despite the sample quality metrics violating the analytical test specifications may be useful when it is desired to gain experience, obtain indicative results, and use the results for stability studies, or when there is a time lag or other problem associated with obtaining additional samples, or when medical samples are expensive.
[0018] If the compliance status indicates whether the medical sample is unprocessable, the step of determining the compliance status may further include determining whether the or each medical sample arrived at its intended destination (e.g., a laboratory), was lost, spilled, otherwise contaminated or tampered with, or whether the sample's identification label (e.g., barcode) was lost or became unreadable, or whether the medical sample was not collected because, for example, there was insufficient time to collect the sample, the patient's condition / situation meant that the sample could not be collected (e.g., blood is not flowing well and the patient's vein cannot be accessed), the patient was not available to provide the sample, due to an error on the part of the sample collector, the required type of sample container was no longer available, etc. This may assist in reducing the number of medical samples with a compliance status indicating that the sample is unprocessable by identifying the causes of the sample becoming unprocessable.
[0019] When a sample quality metric is referenced, the metric may include one or more parameters or statistics. The quality metric (whether a parameter or a statistic) may have a threshold above which the compliance status is considered valid and below which the compliance status is considered negative.
[0020] The method may further include deriving a sample quality metric for the or each medical sample. The steps include obtaining sample data including one or more of sample collection information, sample transport information, sample centrifugation information, and sample storage condition information, and deriving the sample quality metric based on the sample data. The sample data (200) may be obtained from a remote agent. The remote agent may be, for example, one or more sensors in a transport device to which the sample is transported. The analytical test management system may be communicatively connected to the sensors and obtain the sample data from the sensors. In another embodiment, the remote agent may be, for example, a processor in a computer located at the sample collection site. The processor may include sample data related to the sample collection, such as, for example, the patient's condition, or whether the sample was not properly collected, or the collection time. Further examples of such sample data are provided below. The analytical test management system may be communicatively connected to the processor to obtain the sample data (200).
[0021] The sensors may measure, for example, temperature or humidity during transport.
[0022] Advantageously, the sample quality metric is based on sample data, meaning that the sample quality metric reflects information related to whether a medical analytical test can be successfully performed on the medical sample.
[0023] The collection information for a given sample may include one or more of a collection timestamp, patient data, collection observations, an image of the sample after collection, and sample fixation time.
[0024] The patient data may include one or more of a patient ID and patient demographics.
[0025] The sample transport information may include one or more of: sample temperature measurements during transport, sample light exposure measurements during transport, sample impact exposure measurements during transport, sample container additional information, and GPS data.
[0026] The sample centrifugation information may include one or more of an indication of whether centrifugation occurred, a collection time measurement until centrifugation, and centrifugation specifications.
[0027] The sample storage condition information may include one or more of a temperature measurement during storage, a sample light exposure measurement during storage, a humidity measurement during storage, a sample shock exposure measurement during storage, and a storage period measurement.
[0028] The step of determining the compliance status of the or each medical sample with respect to the assigned analytical test may include either obtaining, for the or each medical sample, from a remote device an indication of whether the sample quality metric of the medical sample violates the analytical test specification of its assigned analytical test in the initial assignment, or obtaining the sample quality metric of each medical sample, obtaining the analytical test specification of the or each analytical test in the initial assignment, and performing a compliance process that evaluates for the or each medical sample whether the sample quality metric violates the analytical test specification of its assigned analytical test in the initial assignment. Advantageously, determining the compliance status via the remote device may avoid duplication of the compliance process in case the compliance process has already been performed by the remote device. Determining the compliance status via a computer system that performs the compliance process (rather than obtaining the compliance status from a third party that performs the compliance process) may be advantageous since it does not require providing the test specification to the third party. In particular, if the test specification is based at least in part on information obtained from a laboratory operator, it may be desirable from the standpoint of information security and confidentiality not to provide the test specification based on this data to the third party.
[0029] The process of modifying the allocation may be performed via a remote device or directly by the computer implementing the method. The modification may include re-matching one or more medical samples to one or more analytical tests in the initial allocation. Such re-matching may be based on knowledge of which of one or more analytical tests in the initial allocation each medical sample complies with. Advantageously, such re-matching may allow all analytical tests present in the initial allocation to be performed validly, even if the initial allocation of medical samples to analytical tests resulted in one or more invalid tests being performed.
[0030] Sample quality metrics may include hemoglobin, icterus and lipidemia indices. In one embodiment, sample quality metrics do not include a hemolytic index (e.g., H-index).
[0031] Analytical test specifications may be derived from one or more of the following: IVD vendor information, laboratory requirements (by laboratory operators), data indicating best practices and general guidelines, and tube manufacturer guidelines. Additionally, analytical test specifications can be specific to an analytical test or a family of tests resulting from harmonized / standardized test codes, e.g., LOINC, SNOMED(CT), JLAC10 and / or C-NPU codes.
[0032] Analytical test specifications may be derived based on harmonized / standardized test codes and / or alternative descriptions of analytical tests. Using both test codes and alternative descriptions of analytical tests is advantageous when there is no one-to-one mapping between test codes and analytical tests.
[0033] The analytical test specifications for the analytical test may be obtained from a test supplier or a sample container manufacturer. Alternatively, the analytical test specifications may be obtained from a database, where the test specifications in the database are based on one or more of information obtained from the test supplier, information obtained from the sample container manufacturer, and information obtained from a laboratory operator. The database may be internal to the computer system or may be accessible by the computer system via a network connection.
[0034] The method may further include determining a total of test specification violations due to the initial assignment. In that case, revising the assignment may include performing a minimization optimization with the total of test specification violations as an objective function. Such a method may maximize the number of analytical tests listed in the initial assignment that can still be run with the revised assignment of samples to analytical tests if it is not possible to arrive at a revised assignment that is free of test specification violations.
[0035] Minimization optimization may be a method or algorithm that works to minimize the total number, sum, or weighted sum of test specification violations by modifying initial allocations based on a set of constraints and relationships between one or more decision variables. Optimization may use a model that includes one or more decision variables (e.g., which tests should be performed on which samples), an objective function (e.g., the total number, sum, or weighted sum of test specification violations), and one or more constraints (e.g., do not exceed the available net volume of samples). Data regarding the decision variables, objective function, and constraints for laboratory optimization may be obtained from sample order data, test specifications, and sample quality metrics. Minimization optimization may be configured such that the priority of analytical tests to be performed is incorporated into the objective function along with the number of test specification violations, e.g., a weighted sum of test specification violations may use the priority as a weight. Objective function may refer to any mathematical function that the optimization attempts to maximize or minimize while adhering to a set of constraints and considering relationships between one or more decision variables.
[0036] The step of modifying the allocation may further include identifying a medical sample whose sample quality metric violates the analytical test specification of its assigned analytical test in the initial allocation, identifying an alternative analytical test for the medical sample other than the assigned analytical test in the initial allocation, whose sample quality metric does not violate the analytical test specification of the medical sample, and modifying the allocation so that the medical sample is assigned to the alternative analytical test. Advantageously, this method allows for more efficient utilization of the medical sample by avoiding samples (and laboratory resources) being wasted by non-compliant tests performed on the sample, and by avoiding samples being discarded due to non-compliance with the test originally assigned to the sample. These additional processes in the step of modifying the allocation may be performed by a third party and provided to the analytical test management system, or the analytical test management system itself may perform these additional processes.
[0037] The alternative analytical test may be a test present in the initial assignment. This is advantageous if the medical sample originally assigned to this alternative analytical test has a sample quality metric that does not violate the analytical test specifications of the analytical test whose test specifications were violated by the sample quality metric of the originally assigned medical sample. In such a case, the analytical test assigned to the medical sample can be directly replaced.
[0038] Alternatively, the alternative analytical test may be a test not present in the initial allocation. The alternative analytical test may be a test that may be performed for the same purpose as the assigned test in the initial allocation, where the specification was violated by the sample metric of the initially assigned donor. For example, the alternative analytical test may be a test for the same purpose (and possibly the same parameter) from a different donor. Advantageously, this may allow for obtaining values for the same parameters from testing of the sample, even if there is a test specification violation in the initial allocation of the medical sample to the analytical test.
[0039] The method may further include a step of evaluating, for the or each medical sample, whether its sample quality metric violates an analytical test specification for the or each analytical test in the initial assignment other than the assigned analytical test in the initial assignment. Such a step may be useful when a step of modifying the assignment of medical samples to analytical tests is subsequently performed.
[0040] The step of modifying the allocation of medical samples to analytical tests may further include identifying medical samples whose sample quality metrics violate all analytical test specifications for the analytical test in the initial allocation, determining that there is no alternative analytical test for the medical sample that is not present in the initial allocation whose sample quality metrics do not violate the analytical test specifications, and removing the medical sample from the allocation. In one embodiment, the analytical test management system sends instructions to the laboratory scheduling system to remove the medical sample from the initial allocation before processing the medical sample. Advantageously, this avoids performing analytical tests on medical samples that have been proven to invalidate the results of such analytical tests, thereby reducing resource usage and facilitating increased useful laboratory throughput.
[0041] If the medical sample is removed from the allocation, the method may further include requesting a new medical sample to replace the medical sample in the allocation. This facilitates performing the intended analytical test to obtain the desired test result when the new medical sample is provided. The request for the new sample may be made prior to processing the medical sample. This saves costs, resources, and time.
[0042] The initial allocation may further include a priority of the analytical tests indicating the priority with which each test should be performed. The step of modifying the allocation may be based in part on the priority. Advantageously, this may ensure that the most important analytical tests are prioritized when modifying the allocation, so that even after modification of the allocation, even if not all of the analytical tests of the initial allocation can be performed, these most important analytical tests are still performed.
[0043] The priority may be a weighted sum, e.g., based on factors including how suitable a given sample is for a given test (e.g., how clinically comparable the results are), whether the test is given "urgent" status, what fraction of the sample volume is used by a given test, the time sensitivity to obtain test results, and whether the test result is essential or ancillary, e.g., for diagnosis. The priority may be based on test orderer preferences. The priority may be based on laboratory preferences. Laboratory preferences may reflect time to result output, sample stability for performing the test, sample container information (e.g., size, compatibility with laboratory equipment), availability of reagents, and condition of equipment for testing.
[0044] The method may further include distributing the revised assignment to a laboratory information system, a healthcare information system, or a laboratory information management system.
[0045] The step of modifying the allocation may further include allocating the medical sample to more than one analytical test. If the medical sample is allocated to multiple analytical tests, the method may further include directing the creation of an aliquot from the sample. This allows a greater percentage of analytical tests to be performed when there is a one-to-one match between the medical sample and the analytical test and there is no compliant medical sample that would otherwise be allocated to that analytical test.
[0046] The method may further include, following modification of the allocation, forwarding instructions to a laboratory scheduling system for processing the medical sample and generating test results in accordance with the modified allocation.
[0047] Thus, the benefits of the revised allocation, including avoiding delays to subsequent medical intervention caused by invalid test results, avoiding wasting resources performing tests that yield invalid results, and improving laboratory throughput, may be realized without human intervention.
[0048] Alternatively, the revised allocation may be provided to an indication means, in such a case, the method may further include providing an indication of the medical samples that, in the revised allocation, violated analytical test specifications for the assigned analytical test of the medical samples.
[0049] In a second aspect, an analytical test management system is provided for optimizing the allocation of one or more medical samples to one or more analytical tests performed on these medical samples. The system comprises an optimization module configured to obtain an initial allocation of one or more medical samples to one or more analytical tests, and a compliance module configured to determine, for the or each medical sample, a compliance status indicative of: (i) whether a sample quality metric of the or each medical sample violates an analytical test specification of the assigned analytical test of the medical sample in the initial allocation, and / or (ii) whether the or each medical sample is unprocessable. The optimization module is further configured to perform mitigation measures prior to processing of the medical sample in an analytical laboratory if the one or more compliance statuses indicate that (i) a sample quality metric of a given medical sample violates an analytical test specification and / or (ii) whether the given sample is unprocessable, and the mitigation measures include modifying the allocation of the medical sample to the analytical test based on the or each compliance status.
[0050] Alternatively, the optimization module may be located within a third party system configured to communicate with the analytical test management system.
[0051] Such a system can determine whether a given medical sample is compliant with its assigned analytical test, and therefore whether the assigned analytical test (i) is likely to provide a valid result if performed on the medical sample, and / or (ii) can be performed on the medical sample (whether the result is likely to be valid or invalid). By taking mitigating actions as required by the outcome of this determination, the system can reduce wasteful consumption of resources (e.g., both laboratory resources and sample collection resources) and increase useful laboratory throughput. Furthermore, the above method may result in better patient health outcomes, where patients avoid waiting for analytical test results that turn out to be invalid due to poor sample quality, thus enabling them to receive appropriate medical interventions earlier.
[0052] The mitigation action may include amending the assignment of medical samples to analytical tests based on the or each compliance status for the analyses assigned to the samples according to the amended assignment. Mitigation actions including amending the assignment of medical samples to analytical tests may enable a reduction in the number of medical samples that are discarded because they are found to not comply with the analytical test specifications of the tests that they were originally assigned to.
[0053] The mitigating action may include the further step of flagging and / or disabling the test order associated with the medical sample and the respective analytical test based on the or each compliance status. In a further embodiment, the flagging and / or disabling of the test order results in a flagged test result when the medical sample is processed according to the revised allocation.
[0054] This allows laboratory operators to be alerted to invalid test orders / results and prevent them from relying on them.
[0055] The mitigation action may include notifying an operator of a violation of the analytical test specifications, which may include (i) one or more proposed modifications to the allocation of medical samples to analytical tests, (ii) a notification and / or a flag based on the or each compliance status, and / or (iii) an indication that the test order and / or test results associated with the analytical test are invalid based on the or each compliance status.
[0056] The optimization module may be configured to derive a sample quality metric for the or each medical sample by obtaining sample data including one or more of sample collection information, sample transport information, sample centrifugation information, and sample storage condition information, and being configured to derive a sample quality metric based on the sample data.
[0057] The compliance module may be configured to determine the compliance status by obtaining, for the or each medical sample, from a remote device an indication of whether a sample quality metric of the medical sample violates the analytical test specification of its assigned analytical test in the initial assignment, or by being configured to perform a compliance process to obtain, for the or each medical sample, a sample quality metric, obtain the analytical test specification of the or each analytical test in the initial assignment, and evaluate, for the or each medical sample, whether a sample quality metric violates the analytical test specification of its assigned analytical test in the initial assignment (300).
[0058] The optimization module may be configured to modify the assignment by identifying a medical sample whose sample quality metric violates an analytical test specification for its assigned analytical test in the initial assignment, identifying for the medical sample an alternative analytical test other than the assigned analytical test in the initial assignment whose sample quality metric does not violate the analytical test specification for the medical sample, and modifying the assignment such that the medical sample is assigned to the alternative analytical test. The alternative analytical test may be a test present in the initial assignment or may be a test not present in the initial assignment.
[0059] The compliance module may be further configured to evaluate, for the or each medical sample, whether the sample quality metric violates an analytical test specification for the or each analytical test in the initial assignment other than the assigned analytical test in the initial assignment.
[0060] The optimization module may be configured to modify the allocation by identifying a medical sample whose sample quality metric violates all of the analytical test specifications for the analytical test in the initial allocation, determining that there is no alternative analytical test not present in the initial allocation for the medical sample whose sample quality metric does not violate the analytical test specifications, and configured to remove the medical sample from the allocation. The optimization module may be configured to request a new medical sample to replace the medical sample in the allocation.
[0061] In some examples, the initial allocation may further include a priority of the analysis tests indicating the priority with which each test should be performed, and the optimization module may modify the allocation based in part on the priority.
[0062] The optimization module may be configured to modify the allocation by being further configured to allocate the medical sample to more than one analytical test, in which case the system may direct the creation of an aliquot from the sample.
[0063] The optimization module may be configured to provide the revised allocation to a laboratory scheduling system for automatic implementation of the revised allocation.
[0064] The optimization and compliance modules discussed herein may be implemented as software or elements of a software suite running on one or more computers.
[0065] The system may be a laboratory information system. The system may be a healthcare information system. The system may be a hospital information system. The system may be a laboratory information management system.
[0066] The system may be a centralized system in that each module may be located on the same computer or local computer network, or it may be a decentralized system in that one or more of the modules may be located on a different computer or local computer network than one or more other modules.
[0067] The system may be implemented as laboratory middleware.
[0068] The system may be in network communication with a sample transport system (e.g., a conveyor within a laboratory, or a vehicle transporting the medical sample or each medical sample) or a transport box containing the medical sample or each medical sample (e.g., a pre-analysis transport box) so that sample data can be acquired during transport of the sample.
[0069] In a third aspect, there is provided a computer-implemented method for assessing suitability of one or more medical samples for one or more analytical tests, the method comprising the steps of obtaining a sample quality metric for the, or each, medical sample; obtaining an analytical test specification for the, or each, analytical test; performing a compliance process for evaluating, for the, or each, medical sample, whether the sample quality metric violates the analytical test specification for the, or each, analytical test; and outputting, for each medical sample, an indication of whether the sample quality metric violates the analytical test specification for the medical sample or each, analytical test.
[0070] The present invention includes combinations of the described embodiments and preferred features unless such combinations are expressly not permitted or explicitly avoided. [Brief description of the drawings]
[0071] BRIEF DESCRIPTION OF THE DRAWINGS Embodiments and experiments illustrating the principles of the present invention will now be described with reference to the accompanying drawings.
[0072] [Figure 1] FIG. 1 is a block diagram illustrating an analytical test management system in a network. [Diagram 2] 1 is a flow chart of a method for optimizing the allocation of one or more medical samples to one or more analytical tests performed on those medical samples. [Diagram 3] FIG. 1 is a block diagram illustrating an analytical test management system in a network. [Figure 4] 1 is a flow chart of a method for obtaining sample quality metrics of a medical sample. [Diagram 5] 1 is a flow chart of a method for determining a compliance status of one or more medical samples with one or more analytical tests listed in an initial assignment of the medical sample to an analytical test. [Figure 6]3 is a flowchart of a method for optimizing the allocation of one or more medical samples to one or more analytical tests performed on those medical samples, the flowchart being a modification of that of FIG. 2. [Figure 7A] FIG. 1 illustrates the initial allocation of medical samples to analytical tests. [Figure 7B] FIG. 1 shows the results of determining the compliance status of these medical samples to analytical testing. [Figure 7C] FIG. 1 illustrates the revised allocation of medical samples to analytical tests. [Figure 8A] FIG. 1 illustrates the initial allocation of medical samples to analytical tests. [Figure 8B] FIG. 1 shows the results of determining the compliance status of these medical samples to analytical testing. [Figure 8C] FIG. 1 illustrates a possible revised allocation of medical samples to analytical tests. [Figure 8D] FIG. 1 illustrates a possible revised allocation of medical samples to analytical tests. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0073] Aspects and embodiments of the present invention will now be described with reference to the accompanying figures. Further aspects and embodiments will be apparent to those skilled in the art.
[0074] FIG. 1 is a block diagram illustrating an analytical test management system 10 in a network. The analytical test management system 10 may be implemented as or within a laboratory information system, a healthcare information system, or a laboratory information management system. The system 10 is configured in a network to optimize the allocation of one or more medical samples to one or more analytical tests performed on those samples. An initial allocation of medical samples to analytical tests is provided to the system 10 from a laboratory scheduling system 20 with which the system 10 is in network communication. The system 10 is also in network communication with one or more third parties 40 in the form of applications or services usable by the system 10 to obtain information for optimizing the allocation of medical samples to analytical tests. The system 10 communicates with the third parties 40 to determine, for each medical sample, a compliance status indicating (i) whether the sample quality metric of the or each medical sample violates the analytical test specification of the assigned analytical test of the medical sample or each medical sample in the initial allocation, and / or (ii) whether the or each medical sample is unprocessable. This determination is based in part on sample data 200 collected by the third parties 40 for the medical sample. The determination is also based on the analytical test specification 300 for the test in the initial allocation obtained by the system 10 and / or the third party 40 (depending on how the compliance status determination is made as further described in connection with FIG. 4 below). The test specification 300 may be based on several sources of information, including data from a test supplier 310, data from a container manufacturer 320 whose containers will be used during the test, and data from a laboratory operator 330, for example reflecting experience gained in performing previous tests. The analytical test specification 300 used in determining the compliance status of the medical sample with respect to the analytical test is retrieved by the analytical test management system 10 and / or the third party 40 using a combination of the test code, e.g., the LOINC code, and the analytical test description.Upon obtaining the compliance status of the medical samples for the respective analytical tests, the system 10 may perform an optimization process prior to processing the medical samples in the analytical laboratory to reduce the total number of test specification violations and / or the number of samples that cannot be processed. The optimized allocation of medical samples to analytical tests is output from the analytical test management system 10 to the laboratory scheduling system 20. The optimization of the allocation of medical samples to analytical tests may be performed by a third party and the optimized allocation may then be provided by the third party to the analytical test management system 10 for distribution to the laboratory scheduling system 20, or the analytical test management system 10 itself may perform the optimization.
[0075] Figure 2 is a flow chart illustrating a computer-implemented method for optimizing the allocation of one or more medical samples to one or more analytical tests performed on those samples. The method illustrated in Figure 2 may be implemented by an analytical test management system 10 as illustrated in Figure 3. For a given analytical test to be successfully performed on a medical sample and produce a valid result, the medical sample should (i) have a sample quality metric that complies with the analytical test specification for the given analytical test, and (ii) be processable.
[0076] Typically, a medical specimen is found to be unprocessable if one or more of the following events occur: the medical specimen does not arrive at its intended destination (e.g., a laboratory) where analytical testing was to be performed on the medical specimen, the medical specimen is lost, the medical specimen is spilled or otherwise contaminated or tampered with, the medical specimen was not collected, or the specimen's identification label (e.g., bar code) is lost or becomes unreadable.
[0077] Analytical test specifications 300, on the other hand, specify values for one or more metrics that a sample must meet in order for that analytical test to be performed on the sample. For example, test specifications 300 may relate to parameters such as the time between obtaining the sample and performing the test on the sample, minimum and maximum temperature exposure, centrifuge settings (if centrifugation is required), the time between obtaining the sample and performing the centrifugation (if centrifugation is required), light exposure, maximum and minimum humidity exposure, shock exposure, and sample container characteristics.
[0078] In step S100, an initial allocation 100 of medical samples to analytical tests is obtained. In FIG. 3, this is obtained by the optimization module 11 via the input / output (I / O) module 13. Typically, medical samples are collected with a specific analytical test in mind for each medical sample, and the initial allocation 100 reflects the pairing of medical samples and analytical tests. Although a one-to-one relationship between samples and tests is common, it is also possible for the initial allocation 100 to indicate that more than one analytical test is to be performed on a sample. Multiple analytical tests may be performed on a sample by creating aliquots from the sample, or if the preceding analytical tests do not alter the sample.
[0079] In step S300, the compliance status of each medical sample in the initial allocation 100 with respect to its corresponding analytical test is determined. The analytical test management system 10 includes a compliance module 12 for performing step S300. In this example, a medical sample described as "compliant" with an analytical test may be understood to (i) be processable (i.e., not unprocessable) and (ii) have one or more sample quality metrics that each comply with (i.e., do not violate) the analytical test specification 300. However, as described above, in other examples, only one of (i) and (ii) may be determined, or the determination of (ii) may depend on a positive finding from the determination of (i). That is, the compliance module 12 may first determine that the medical sample is processable and then determine (ii) only for each medical sample found to be processable. If either (i) or (ii) is determined to be negative (the sample is not processable or violates the analytical test specification), the overall compliance status of the medical sample may be considered to be negative (i.e., not compliant with at least one of (i) and (ii)).
[0080] One method for determining the compliance status of each medical sample with respect to an analytical test is to obtain, for each medical sample, from a remote device an indication of whether the sample's sample quality metrics violate its assigned analytical test's analytical test specifications 300. For example, the remote device may be included within the system that originally acquired the medical sample and placed the analytical test order, which system may already take into account the compliance status of the sample.
[0081] However, the system 10 of FIG. 3 is configured to internally use the sample data 200 and test specifications 300 acquired via the I / O module 13 to determine the compliance status of the medical sample with respect to the assigned analytical test. The steps involved in the system 10 of FIG. 3 to determine the compliance status are shown in FIG. 4 and further described below. The system 10 shown in FIG. 3 acquires the test specifications 300 from an external source, i.e., a third party 40, such as a test supplier and / or a sample container manufacturer. This is typically done by providing the third party 40 with the LOINC code and / or another description of each analytical test, which the third party 40 can use to identify the appropriate test specification 300 to return to the system 10. However, the test specifications 300 may also be acquired from a database 14 internal to the system 10. The database 14 may store test specifications 300 previously referenced by the system 10, or may store test specifications 300 that have been modified from those provided by the third party 40 (e.g., where feedback from the laboratory performing the corresponding analytical test has been incorporated into the test specifications 300).
[0082] The compliance status determined in step S300 may also indicate that the medical sample is unprocessable. In such a case, the system 10 may be further configured to determine what the root cause of the medical sample being found to be unprocessable was (e.g., whether the sample was lost, did not arrive at the intended destination, etc.). Whether a sample is unprocessable may be determined internally by the system (e.g., if the sample data 200 for that sample is missing) or by a third party 40 informing the system 10 that the sample is unprocessable (e.g., if the third party 40 knows that the sample was lost in transit).
[0083] After determining the compliance status of each medical sample with respect to the assigned analytical test, step S500 involves checking whether there is at least one negative compliance status, i.e., whether the total number of violations of test specifications 300 (i.e., the sum of the number of medical samples having sample quality metrics that violate the test specifications 300 of the respective analytical tests assigned to the medical samples in the initial assignment 100) and / or whether the total number of unprocessable samples is greater than zero. If the check in step S500 is no (no negative compliance status), the system 10 does not proceed to execute mitigating measures (step S800), since it has been established that the initial assignment of medical samples to analytical tests was appropriate and / or that all medical samples are processable. However, if the check at step S500 is yes (there is at least one negative compliance status), the system 10 proceeds to method step S700, where mitigating action is taken by the optimization module 11 in response to a determination that the initial allocation 100 of medical samples to analytical tests results in a violation of the analytical test specification 300 (i.e., the tests listed in the initial allocation 100 are likely to return invalid results) and / or that one or more of the samples listed in the initial allocation 100 are unprocessable (i.e., the corresponding tests listed in the initial allocation 100 cannot be performed on the sample).
[0084] One possible type of mitigation action is for the optimization module 11 to modify the allocation of medical samples to analytical tests based on the compliance status of the medical samples. This type of mitigation action is further described in relation to Figures 6-8 below. For example, if the allocation can be modified by swapping the assignment of two samples to two respective tests (see, e.g., Figures 7A-7C, in which tests T2 and T4 have been swapped between their initial assignment (Figure 7A) and their revised assignment (Figure 7C)), the number of medical samples discarded because their sample quality metrics were found to not comply with the analytical test specifications 300 of the tests to which they were originally assigned can be reduced and the proportion of viable tests listed in the initial assignment 100 can be increased. The modification is typically performed by performing a minimization optimization with the sum of test specification violations as an objective function.
[0085] Another possible type of mitigation action is for the optimization module 11 to additionally flag and / or invalidate test orders and / or test results associated with medical samples that have a compliance status indicating that (i) the sample quality metrics of the medical sample or each medical sample violate the analytical test specifications 300 of the assigned analytical test of the medical sample in the revised allocation, and / or (ii) each medical sample cannot be processed.
[0086] In step S900, the assignments and any flags that have been raised are output from the system 10 via the I / O module 13. The flags, if any, may be notified to the lab operator via the display means 30. The revised assignments, if any, may be notified to the lab operator for review via the display means 30. Notification to the operator may be merely for informational purposes, or the revised assignments may be implemented automatically by the lab scheduling system 20. Alternatively, notification may be such that the operator can decide to accept or reject the proposed revised assignments.
[0087] Figure 4 illustrates how the system 10 of Figure 3 determines the compliance status of a medical sample with respect to an analytical test assigned in the initial assignment 100. In Figure 4, for simplicity, it is assumed that each medical sample has a single sample quality metric and that each test specification specifies a value for that sample quality metric. However, as discussed above, it is possible for a medical sample to have multiple sample quality metrics, all of which must comply with the test specifications for the medical sample to be compliant with its analytical test.
[0088] In step S310, n sample quality metrics are obtained by the compliance module 12, each sample quality metric corresponding to a respective medical sample listed in the initial allocation 100 obtained by the system 10 (i.e., n medical samples are listed in the initial allocation 100). The step of obtaining sample quality metrics is further described in relation to FIG. 5. In step S320, m test specifications 300 are obtained by the compliance module 12, each test specification 300 corresponding to a respective analytical test listed in the initial allocation 100 obtained by the system 10. Steps S310 and S320 may be performed in parallel with each other or sequentially with each other in any order.
[0089] In step S330, compliance module 12 performs a compliance process based on the sample quality metrics obtained in steps S310 and S320, respectively, and the test specifications 300. For the method shown in FIG. 4, the determined compliance status indicates whether the sample quality metrics of the medical sample violate the test specifications 300 of the respective analytical tests listed in the initial assignment 100.
[0090] Step S330 includes multiple sub-steps representing an iterative process of performing m tests, each sub-step determining the compliance status of a respective medical sample. As step S331, a counter i of the iterative process is set to 0. In step S332, a test specification i is selected from the m test specifications 300. Then, in step S333, a search is performed to determine the sample corresponding to the test to which the test specification i is associated, using the initial assignment 100. Then, in step S334, a sample quality metric corresponding to the sample searched in step S333 is selected. In step S335, a comparison of the sample quality metric with the test specification i is used to determine whether the sample quality metric violates the test specification 300. Depending on the outcome of step S335, a violation of the test specification 300 (step S336) or a non-violation of the test specification 300 (step S337) is recorded as the compliance status of the medical sample for the assigned analytical test i. Step 338 then checks whether all of the test specifications 300 have been considered, if not all of the test specifications 300 have been considered then the method returns via step S339 to step S332 to select the next test specification 300, if all of the test specifications 300 have been considered then the compliance processing step S330 is complete.
[0091] Figure 5 illustrates how step S310 of Figure 4 for obtaining sample quality metrics for the medical samples listed in the initial allocation 100 may be performed. The method of Figure 5 is for obtaining sample quality metrics for a single medical sample. This method may be repeated until sample quality metrics for all medical samples listed in the initial allocation 100 are obtained.
[0092] In step S311, sample data 200 is acquired. The sample data 200 is information about a medical sample acquired from a data source external to the system 10, and thus the sample data 200 is acquired by the compliance module 12 of the system 10 via the I / O module 13, which communicates with the external data source. The sample data 200 may include one or more of sample collection information, sample transportation information, sample centrifugation information, and sample storage condition information. The collection information for a given sample may include one or more of collection timestamp, patient data, collection observation, image of the sample after collection, sample fixation time. The patient data may include one or more of patient ID and patient demographics. The sample transportation information may include one or more of sample temperature measurements during transportation, sample light exposure measurements during transportation, sample impact exposure measurements during transportation, and sample container appendage information, and GPS data. The sample centrifugation information may include one or more of an indication of whether centrifugation occurred, collection time measurements until centrifugation, and centrifugation specifications. The sample storage condition information may include one or more of a temperature measurement during storage, a sample light exposure measurement during storage, a humidity measurement during storage, a sample shock exposure measurement during storage, and a storage period measurement.
[0093] In step S312, a sample quality metric for the medical sample is derived based on the sample data 200 for that sample. Where a sample quality metric is referenced, the metric may be a parameter or a statistical value. Also, where a single sample quality metric is referenced, there may be multiple sample quality metrics and the sample quality metric may be a combination of one or more parameters and / or one or more statistical values. Common sample quality metrics are hemoglobin (H), icterus (I), and lipemic (L) indices (H / I / L index) in serum or plasma.
[0094] Figure 6 is a flow chart of a method for optimizing the allocation of one or more medical samples to one or more analytical tests performed on those medical samples. The flow chart of Figure 6 is a variation of the flow chart of Figure 2. Figure 6 includes an additional step S600 of determining, for each sample, whether its sample quality metric violates the analytical test specification 300 of each analytical test in the initial allocation 100 other than its assigned analytical test in the initial allocation 100. Figure 6 also includes additional details of step S700 regarding the sub-steps involved in performing an example of a mitigating action.
[0095] The method illustrated by the flow chart of Figure 6 is described below in relation to Figures 7A-7C and 8A-8D. Figure 7A is a table showing an initial allocation 100 of four medical samples (S1-S4) to four analytical tests (T1-T4). Figure 7B is a table showing the compliance status (Y or N, corresponding to compliant and non-compliant, respectively) of each of the sample quality metrics of the medical samples S1-S4 with respect to each of the test specifications 300 of the analytical tests T1-T4 of Figure 7A. Figure 7C is a table showing the revised allocation of the medical samples S1-S4 to the analytical tests T1-T4. Similar to FIG. 7A, FIG. 8A is a table showing an initial allocation 100 of four medical samples S1-S4 to four analytical tests T1-T4, but FIG. 8A also includes an analytical test priority indicating the priority with which each test should be performed, with test T2 ranked highest (most important to perform) and test T4 ranked lowest (least important to perform). Similar to FIG. 7B, FIG. 8B is a table showing the compliance status (Y or N, corresponding to compliant and non-compliant, respectively) of each of the sample quality metrics of the medical samples S1-S4 with respect to each of the test specifications 300 of the analytical tests T1-T4 of FIG. 8A. FIGS. 8C and 8D are tables with alternative revised allocations of medical samples to analytical tests T1-T4.
[0096] Steps S100, S300, S500, S800 and S900 in FIG. 6 are the same as steps S100, S300, S500, S800 and S900 described above in connection with FIG. 2, and therefore the description of these steps will be omitted from the description of FIG.
[0097] The flowchart of FIG. 6 differs from the flowchart of FIG. 2 in that if the check at step S500 is yes, the flowchart of FIG. 6 proceeds to step S600, where it is determined for each medical sample in the initial allocation 100 whether its sample quality metric violates the analytical test specifications 300 of each analytical test in the initial allocation 100 other than its assigned analytical test in the initial allocation 100. Step S600 is performed by the compliance module 12 in the system 10 of FIG. 3. In FIG. 6, step S600 is shown to include a number of sub-steps S610-S650 that constitute an iterative loop for evaluating each medical sample. In step S610, a counter i for the iterative process is set to 0. In step S620, a medical sample i is selected from the n medical samples. Step S630 then includes evaluating whether the sample quality metric of medical sample i violates the analytical test specifications 300 of tests not assigned in the initial allocation 100, and the result is recorded. Step S640 then checks whether all medical samples have been considered, if not all medical samples have been considered, the method returns to step S620 via step S650 to select the next medical sample, if all medical samples have been considered, step S600 is complete.
[0098] 7A and 7B, in the case of the initial assignment 100 of FIG. 7A, as FIG. 7A and FIG. 7B show, sample S2 is initially assigned to test T2, but since the sample quality statistics of S2 violate the test specifications 300 of T2, the check in step S500 is yes, which means the method proceeds to step S600. Step S600 of FIG. 6 can be understood as determining whether the sample quality metric of sample S1 violates the test specifications 300 of analytical tests T2-T4 (because S1 is assigned to T1 in FIG. 7A), whether the sample quality metric of sample S2 violates the test specifications 300 of analytical tests T1, T3 and T4 (because S2 is assigned to T2 in FIG. 7A), whether the sample quality metric of sample S3 violates the test specifications 300 of analytical tests T1, T2 and T4 (because S3 is assigned to T3 in FIG. 7A), and whether the sample quality metric of sample S4 violates the test specifications 300 of analytical tests T1-T3 (because S4 is assigned to T4 in FIG. 7A). The result of step S600 is shown in FIG. 7B, where sample S2 is compliant with test T4 and sample S4 is compliant with test T2, but otherwise the medical sample is not compliant with a test that was not assigned in the initial assignment 100.
[0099] Following step S600, the flowchart of Figure 6 proceeds to step S700, where mitigating actions are taken by optimization module 11 of system 10 of Figure 3. The mitigating actions represented by step S700 of Figure 6 are one example of mitigating actions that may be taken in response to a YES determination in step S500. Step S700 of Figure 6 includes a number of sub-steps S710-S760.
[0100] First, in step 710, it is checked whether there are any medical samples in the initial allocation 100 whose sample quality metrics violate all test specifications 300 of all analytical tests in the initial allocation 100. As an example, the table in FIG. 7B does not include any samples that violate all of the test specifications 300 in the initial allocation (even if that test is not the test to which the sample was assigned in the initial allocation 100) because each of the samples S1-S4 is compliant with at least one of the tests T1-T4. In contrast, in FIG. 8B, sample S2 is shown to violate the test specifications 300 of all tests T1-T4 listed in the initial allocation 100. Thus, the check in step S710 is answered as no for the samples and tests in FIG. 7B and as yes for the samples and tests in FIG. 8B.
[0101] Considering first the sample and test example of FIG. 7B, the method proceeds to step S750, where the allocation of medical samples to analytical tests is modified to reduce the total number of violations of test specifications 300 that occur compared to the initial allocation 100. The process of modifying the initial allocation 100 may further include identifying medical samples whose sample quality statistics violate the analytical test specifications 300 of the analytical tests assigned in the initial allocation 100, where sample S2 has a sample quality statistic that violates the analytical test specifications of test T2. Step S750 may further include identifying whether there is an alternative analytical test for medical sample S2 other than its assigned analytical test in the initial allocation 100 whose sample quality metrics do not violate the analytical test specifications 300, where in the case of FIG. 7B, the sample quality statistic of S2 does not violate the test specifications 300 of test T4. Test T4 was assigned to medical sample S4 in the initial allocation 100 (see FIG. 7A), where sample S4 complies with the test specifications 300 of tests T2 and T4 (see FIG. 7B). Thus, the assignments can be revised such that sample S2, which is not compliant with its originally assigned test, is reassigned to an alternative analytical test T4 with which sample S2 complies, and sample S4, which was replaced by S2 because it was assigned to T4, is reassigned to T2, where sample S4 complies with the test specifications 300 of T2. The revised assignments are shown in the table of FIG. 7C. Thus, all analytical tests listed in the initial assignments 100 may be performed on medical samples whose sample quality statistics meet the respective test specifications 300, and all medical samples listed in the initial assignments 100 are used in performing these analytical tests.
[0102] In the example shown in FIGS. 7A-7C, the alternative analytical test T4 to which the sample S2 is reassigned is the analytical test that was in the initial assignment 100.
[0103] Considering the sample and test example of FIG. 8B, the method proceeds from step S710 to step S720 of FIG. 6 since sample S2 violates all analytical test specifications for tests T1-T4 in the initial allocation 100. In step S720, it is checked whether sample S2 complies with an alternative analytical test not present in the initial allocation 100. For example, it is checked whether there is an alternative test that is performed for the same purpose (possibly to obtain the same parameters) as the initially assigned test T2, but with which the sample quality metrics of the test specification sample S2 complies. If it is possible to identify such an alternative analytical test, the method proceeds to step S760, where sample S2 is assigned to the alternative analytical test not present in the initial allocation 100. Following the assignment of the medical sample to an alternative analytical test not present in the initial allocation 100, the method proceeds to step S750, where a further attempt is made to modify the assignment of tests to samples in order to attempt to further reduce the total number of violations. However, it is also possible that the total number of violations is now zero after step S740, in which case the assignment is not further modified in step S750.
[0104] However, in the case of Figures 8A-8D, no such alternative analytical test is identified, and therefore the method proceeds to step S730 of Figure 6. In step S730, medical sample S2 is removed from the sample to test assignment since its sample quality metrics violate all of the test specifications 300 of the tests in the initial assignment 100 and of the alternative analytical tests not in the initial assignment, and therefore will not be used. Subsequently, in step S740, a new medical sample is requested to replace sample S2. The request for a new medical sample may be performed in several different ways. One option, shown in Figure 8C, is that an entirely new sample is requested, in this case sample S5. The compliance status of the newly requested sample S5 may also be determined with respect to the analytical test to which the sample S5 is assigned. An alternative option, shown in Figure 8D, is to assign one medical sample to more than one analytical test. In the case where analytical tests within the multiple analytical tests change samples, the assignment of one medical sample to the multiple analytical tests may include directing the creation of aliquots from the medical sample assigned to the multiple analytical tests. However, allocation of a medical sample to multiple analytical tests may not require the creation of aliquots if the multiple analytical tests do not change the sample (e.g., spectroscopy tests). In Figure 8D, sample S4 is assigned to test T4 (where sample S4 was originally assigned and is in compliance), and an aliquot of sample S4 (denoted S4' in Figure 8D) is assigned to test T2 to replace sample S2 because the sample quality metrics of sample S4 also comply with the analytical test specifications 300 (see Figure 8B) of test T2.
[0105] Further, as discussed above, in Figures 8A, 8C and 8D, a priority order for analytical tests is provided, indicating the priority with which each test should be performed. The step of modifying the assignment to provide the modified assignment of Figure 8C was based on priority. This can be seen by the assignment of Figure 8C, where rather than a new sample being requested for test T2, which is the highest priority test, sample S4 is reassigned to test T2 and the requested new sample S5 is assigned to test T4, which has a lower priority than test T2. In this way, any time lag associated with requesting and obtaining a new sample will delay the ability to perform test T4 rather than test T2, which is preferred if test T2 has a higher priority. The priority order may be a weighted sum based on factors including, for example, how suitable a given sample is for a given test, whether the test is given an "URGENT" status, what percentage of the sample's volume is used by a given test, the time sensitivity of obtaining the test result; whether the test result is essential or ancillary, for example for diagnosis. Typically, the priorities are based on test requester preference and / or laboratory preference.
[0106] Following a request for a new medical sample, the method proceeds to step S750 where a further attempt is made to revise the assignment of tests to samples to attempt to further reduce the total number of violations. However, it is also possible that after step S740 the total number of violations is now zero, in which case the assignment is not further revised in step S750.
[0107] As used herein, the term "laboratory instrument" encompasses any device or instrument component operable to perform one or more processing / workflow steps on one or more biological samples and / or one or more reagents. The term "instrument" encompasses pre-analytical, post-analytical, and analytical instruments.
[0108] The term "analyzer" / "analytical instrument" as used herein encompasses any device or device component configured to obtain measurements. An analyzer is operable to determine parameter values of a sample or its components through various chemical, biological, physical, optical or other technical procedures. An analyzer may be operable to measure a parameter of the sample or at least one analyte and return the obtained measurements. The list of possible analytical results returned by the analyzer includes, but is not limited to, the concentration of the analyte in the sample, a digital (yes or no) result indicating the presence of the analyte in the sample (corresponding to a concentration above the detection level), optical parameters, data obtained from DNA or RNA sequences, mass spectrometry of proteins or metabolites, and various types of physical or chemical parameters. The analytical instrument may comprise units that assist in pipetting, dosing, and mixing of the sample and / or reagents. The analyzer may comprise a reagent holding unit for holding the reagents for performing the analysis. The reagents may be prepared, for example, in the form of containers or cassettes containing individual reagents or groups of reagents and may be placed in suitable containers or positions in a storage compartment or conveyor. It may comprise a consumable supply unit. Analyzers may include process and detection systems whose workflow is optimized for a particular type of analysis, examples of such analyzers include clinical chemistry analyzers, coagulation chemistry analyzers, immunochemistry analyzers, urine analyzers, and nucleic acid analyzers used to detect the outcome of or monitor the progress of a chemical or biological reaction.
[0109] As used herein, the term "pre-analytical equipment" encompasses any device or device component configured to perform one or more pre-analytical workflow steps, including, but not limited to, centrifugation, resuspension (e.g., by mixing or vortexing), capping, decapping, recapping, sorting, tube type identification, sample quality determination, and / or aliquoting steps, which may include adding chemicals or buffers to the sample, concentrating the sample, incubating the sample, etc.
[0110] As used herein, the term "post-analytical equipment" encompasses any device or device component configured to perform one or more post-analytical workflow steps, including, but not limited to, sample removal, transport, re-capping, decapping, temporary storage / buffering, storage (refrigerated or non-refrigerated), retrieval, and / or disposal.
[0111] As used herein, the term "point-of-care device" encompasses any analyzer used in a point-of-care environment, such as (but not limited to) blood glucose testing, coagulation testing, blood gas and electrolyte analysis, urine testing, cardiac marker analysis, hemoglobin diagnostics, infectious disease testing, cholesterol screening, or NAT of nucleic acid testing. Results may be viewed directly on one or more POC analyzers / devices or may be transmitted to and displayed in a healthcare information management system.
[0112] As used herein, the term "connected" encompasses both a direct and an indirect communication path between two or more elements. The communication path may be provided through a physical entity, such as a wired connection, or through a non-physical communication system, such as a network.
[0113] The systems and methods of the above embodiments, in addition to the structural components and user interactions described, may be implemented in a computer system (particularly computer hardware or computer software).
[0114] The term "computer system" includes hardware, software, and data storage for implementing the system or performing the method according to the above-described embodiments. For example, a computer system may include a central processing unit (CPU), input means, output means, and data storage. A computer system may have a monitor that provides a visual output display. The data storage may include RAM, disk drives, or other computer-readable media. A computer system may include multiple computing devices that are connected by a network and can communicate with each other over the network, and in such a case may be referred to as a computer network.
[0115] The methods of the above embodiments may be provided as a computer program, or as a computer program product or computer readable medium carrying a computer program configured to perform one or more of the above methods when executed on a computer.
[0116] The term "computer-readable medium" includes, without limitation, any non-transitory medium that can be read and accessed directly by a computer or computer system. Media may include, but are not limited to, magnetic storage media, such as floppy disks, hard disk storage media, and magnetic tape, optical storage media, such as optical disks or CD-ROMs, electrical storage media, such as RAM, ROM, and memory, including flash memory, and hybrids and combinations of the above, such as magnetic / optical storage media.
[0117] The features disclosed in the foregoing description, or in the following claims, or in the accompanying drawings, and expressed in a specific form or in terms of means for performing a disclosed function or a method or process for obtaining a disclosed result, may be utilized, individually or in any combination of such features, as appropriate, to realize the invention in its diverse forms.
[0118] While the present invention has been described in conjunction with the exemplary embodiments set forth above, many equivalent modifications and variations will be apparent to those skilled in the art given this disclosure. Accordingly, the exemplary embodiments of the present invention set forth above are considered to be illustrative and not limiting. Various changes may be made to the described embodiments without departing from the spirit and scope of the present invention.
[0119] For the avoidance of doubt, any theoretical explanations provided herein are provided for the purpose of enhancing the understanding of the reader, and the inventors do not wish to be bound by any of these theoretical explanations.
[0120] Any section headings used herein are for organizational purposes only and are not to be construed as limiting the subject matter described.
[0121] Throughout this specification, including the claims which follow, unless the context requires otherwise, the words "comprise" and "include", as well as variations such as "comprises", "comprising" and "including", are understood to mean the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps.
[0122] It should be noted that, as used in this specification and the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Ranges may be expressed herein as from "about" one particular value and / or to "about" another particular value. When such a range is expressed, another embodiment includes from the one particular value and / or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent "about," it will be understood that the particular value forms another embodiment. The term "about" with respect to numerical values is arbitrary and may mean, for example, + / - 10%. [Explanation of symbols]
[0123] 10. Analysis and Test Management System 11 Optimization Module 12 Compliance Module 13 I / O Modules 14 Database 20 Laboratory Scheduling System 30 Display means 40 Third party 100 initial allocation 200 Sample Data 300 Test Specifications 310 Testing Supplier Data 320 Container Manufacturer Data 330 Operator Input Data
Claims
1. 1. A computer-implemented method for optimizing the allocation of one or more medical samples to one or more analytical tests performed on those medical samples prior to processing of said medical samples in an analytical laboratory, said method comprising: obtaining an initial allocation (100) of said one or more medical samples to said one or more analytical tests; determining a compliance status of the or each medical sample, the compliance status indicating (i) whether a sample quality metric of the or each medical sample violates an analytical test specification (300) of an assigned analytical test of the medical sample in the initial assignment (100), and / or (ii) whether the or each medical sample is unprocessable; performing mitigating actions prior to processing of the medical sample if one or more compliance statuses indicate that (i) the sample quality metric of a given medical sample violates the analytical test specification (300) and / or (ii) the given medical sample cannot be processed, the mitigating action comprising modifying the allocation of the medical sample to the analytical test based on the or each compliance status; 4. A computer-implemented method comprising:
2. 10. The computer-implemented method of claim 1, further comprising, following the modification of the allocation, forwarding instructions to a laboratory scheduling system to process the medical sample and generate test results in accordance with the modified allocation.
3. 3. The computer-implemented method of claim 1 or 2, wherein the mitigating action further comprises flagging and / or disabling a test order associated with the analytical test based on the or each compliance status of the analytical test for the sample according to a revised allocation.
4. The method further comprises deriving the sample quality metric for the or each medical sample, the deriving comprising: acquiring sample data (200) from a remote agent, the sample data including one or more of: collection information of the sample, transportation information of the sample, centrifugation information of the sample, and storage condition information of the sample; deriving the sample quality metric based on the sample data (200); The computer-implemented method of any one of claims 1 to 3, comprising:
5. determining the compliance status of the or each medical sample, obtaining, for the or each medical sample, from a remote device an indication of whether the sample quality metric of the medical sample violates the analytical test specification (300) of its assigned analytical test in the initial assignment (100); or obtaining the sample quality metric for the or each medical sample; obtaining the analytical test specification for the or each analytical test in the initial allocation (100); performing a compliance process for the or each medical sample to evaluate whether the sample quality metrics violate the analytical test specifications (300) of its assigned analytical test in the initial assignment (100); The computer-implemented method of any one of claims 1 to 4, comprising:
6. The step of modifying the allocation further comprises: identifying medical samples for which a sample quality metric violates the analytical test specification (300) of its assigned analytical test in the initial assignment (100); identifying an alternative analytical test for said medical sample other than the assigned analytical test in said initial assignment (100), the sample quality metric of which does not violate said analytical test specification (300); modifying the allocation so that the medical sample is allocated to the alternative analytical test; The computer-implemented method of any one of claims 1 to 5, comprising:
7. The computer-implemented method of claim 6 , wherein the alternative analytical test is a test present in the initial assignment (100).
8. The computer-implemented method of claim 6 , wherein the alternative analytical test is a test not present in the initial allocation (100).
9. 9. The computer-implemented method of claim 1, further comprising: evaluating, for the or each medical sample, whether its sample quality metric violates the analytical test specification (300) of the or each analytical test in the initial allocation (100) other than its assigned analytical test in the initial allocation (100).
10. The step of modifying the allocation further comprises: identifying medical samples for which a sample quality metric violates all of the analytical test specifications (300) for the analytical tests in the initial allocation (100); determining that there is no alternative analytical test for the medical sample that is not in the initial assignment (100) and whose sample quality metrics do not violate the analytical test specifications (300); removing said medical sample from said allocation; The computer-implemented method of claim 9 , further comprising:
11. The computer-implemented method of claim 10 , further comprising requesting a new medical sample to replace the medical sample in the allocation.
12. the initial assignment (100) further includes a priority order for the analytical tests indicating the priority with which each test should be performed; modifying the allocation is based in part on the priority. A computer implemented method according to any one of claims 1 to 11.
13. The computer-implemented method of any one of claims 1 to 12, wherein the step of modifying the allocation further comprises allocating medical samples to two or more analytical tests.
14. 14. The computer-implemented method of claim 1, wherein the method is performed by an analytical test management system communicatively connected to a laboratory scheduling system (20), the analytical test management system obtaining the initial allocation from the laboratory scheduling system (20) prior to processing the medical sample according to the initial allocation.
15. An analytical test management system (10) for optimizing the allocation of one or more medical samples to one or more analytical tests performed on those medical samples, comprising: an optimization module (11) configured to obtain an initial allocation (100) of said one or more medical samples to said one or more analytical tests prior to processing of said medical samples in an analytical laboratory; A compliance module (12); The compliance module (12) comprises: configured to determine for the or each medical sample a compliance status indicative of (i) whether a sample quality metric for the or each medical sample violates an analytical test specification (300) of an assigned analytical test for the medical sample in the initial assignment (100) and / or (ii) whether the or each medical sample is unprocessable; the optimization module (11) is further configured to, if one or more compliance statuses indicate that (i) the sample quality metric of a given medical sample violates the analytical test specification (300) and / or (ii) the given medical sample is unprocessable, perform mitigating actions prior to processing of the medical sample in an analytical laboratory, the mitigating actions comprising modifying the allocation of the medical sample to the analytical test based on the or each compliance status; An analytical test management system (10).
